Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World Study

Treatment with direct-acting antiviral drugs in interferon-free regimens is currently recommended for viral hepatitis C recurrence after liver transplantation. There are limited data regarding its results in this population, and no optimal treatment scheme has yet been singled out.

Source: Transplantation Proceedings - April 1, 2018 Category: Transplant Surgery Authors: M. Mucenic, A. Bandeira de Mello Brandao, C.A. Marroni, A. Medeiros Fleck, M.L. Zanotelli, G. Kiss, M.H. Meine, I. Leipnitz, E. Soares Schlindwein, J. Martini, A.M. Costabeber, F.K.F. Sacco, G.P. Cracco Cantisani Tags: 15th Brazilian Transplantation Congress and 16th Portuguese-Brazilian Transplantation Congress Source Type: research